期刊文献+

基质金属蛋白酶蛋白表达与胃癌的浸润和转移关系的探讨 被引量:4

下载PDF
导出
出处 《癌症》 SCIE CAS CSCD 北大核心 2002年第5期556-558,共3页 Chinese Journal of Cancer
  • 相关文献

参考文献5

二级参考文献10

  • 1蔡文琴 王伯沄.免疫组织化学和核酸分子杂交技术(第一版)[M].北京:人民卫生出版社,1993.356-478. 被引量:1
  • 2蔡文琴,实用免疫细胞化学与核酸分子杂交技术,1993年,3页 被引量:1
  • 3蔡文琴,免疫组织化学和核酸分子杂交技术,1993年,356页 被引量:1
  • 4Jonbs JL, Walker RA Control of matrix metalloproteinase activity in cancer. J Pathol 1997 ; 183 : 377 - 379. 被引量:1
  • 5Powell WC, Knox JD, Navte M, et al. Expression of the metalloproteinase matrilysin in Du-145 cells increase their invasive potential in severe combined immunodefieient mice.Cancer Res 1993;53:417 - 422. 被引量:1
  • 6Grigioni WF, D'errico A, Fortunato. C, et al. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 1994;7:220- 225. 被引量:1
  • 7Kimura T, lwagaki H, Fuchimoto S, et al. Relationship between type I collagenase activity, invasiveness and metastatic potential in colorectal carcinoma. Cancer 1993; 12:77-80. 被引量:1
  • 8Sehgal G, Hua J, Bemhard EF,et al. Requirement for matrix metalloproteinase-9(geiatinase B) expression in metastasis by murine prostate carcinoma. Am J Pathol 1998; 152:591-596. 被引量:1
  • 9David L, Nesland J, Holm R, et al. Expression of lamin,collagen Ⅳ, fibronectin and type Ⅳ collagenase in gastric carcinoma. Cancer 1994; 13:518 - 527. 被引量:1
  • 10Sier CFM, Kubben FJGM, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 and related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-417. 被引量:1

共引文献30

同被引文献44

  • 1张晓辉,杜金荣,韩丽姝,付红.胃癌E钙粘素和β-连环素的表达及其临床意义[J].哈尔滨医科大学学报,2004,38(5):435-438. 被引量:5
  • 2Still K,Robson CN,Autzen P,et al.Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase 2(TIMP-2) in human benign and malignant protatic tissue.Prostate,2000,42 (2):18-25. 被引量:1
  • 3Gohji K,Fujimoto N.Serum matrix metalloproteinase-2 and density in men with prostate cancer as a new predictor of disease extension.Int J Cancer,1998,79 (11):96-101. 被引量:1
  • 4Arii S,Mise M,Harada T,et al.Overexpression of matrix metalloproteinase-9 gene in hepatocellular carcinoma with invasive potential.Hapatolog,1996,24(2):316-319. 被引量:1
  • 5Okazaki L,Wada N,Nakano M,et al.Difference in gene expression for matrix metalloproteinase-1 between early and hepatocellular carcinomas.Hepatol,1997,25(3):580-584. 被引量:1
  • 6Hayasaka A,Suzuki N,Fujimoto N,et al.Elevated plasma levels of matrix metalloproteinase-9(92kd type collagenase / gelatinase B ) in hepatocellular carcinoma.Hepatol,1996,24 (5):1058-1062. 被引量:1
  • 7Nakatsukasa H,Ashida K,Higashi T,et al.Cellular distribution of transcripts for tissue inhibitor of metalloproteinase -1 and 2 in human hepatocellular carcinomas.Hepatol,1996,24 (1):82-86. 被引量:1
  • 8Hanemaaier R,Verheijen JH,Mayuire YM,et al.Increased gelatinase A and gelatinase-B activities in mallignant vs benign breast tumors.Int Cancer,2000,86,204-207. 被引量:1
  • 9Cawston T.Matrix metalloproteinases and TIMPs properties and implications for the rheumatic disease.Mol Med Today,1998,4(2):130-135. 被引量:1
  • 10Mitsiades N,Yu WH,Poulaki V,et al.Matrix metalloproteinase -7 mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.Cancer Res,2001,61(2):577-581. 被引量:1

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部